Filing Details
- Accession Number:
- 0001209191-10-039278
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2010-07-21 13:00:00
- Reporting Period:
- 2010-07-15
- Filing Date:
- 2010-07-21
- Accepted Time:
- 2010-07-21 19:35:00
- Original Submission Date:
- 2010-07-19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1107332 | Dendreon Corp | DNDN | Pharmaceutical Preparations (2834) | 223203193 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1420482 | W Mark Frohlich | 3005 First Avenue Seattle WA 98121 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-07-19 | 2,855 | $31.42 | 191,605 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Billionaire Hedge Funds
